Maria Rosa Bani

3.1k total citations
62 papers, 2.4k citations indexed

About

Maria Rosa Bani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Maria Rosa Bani has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Maria Rosa Bani's work include Angiogenesis and VEGF in Cancer (13 papers), Ovarian cancer diagnosis and treatment (12 papers) and Protease and Inhibitor Mechanisms (7 papers). Maria Rosa Bani is often cited by papers focused on Angiogenesis and VEGF in Cancer (13 papers), Ovarian cancer diagnosis and treatment (12 papers) and Protease and Inhibitor Mechanisms (7 papers). Maria Rosa Bani collaborates with scholars based in Italy, United States and Canada. Maria Rosa Bani's co-authors include Yaacov Ben‐David, Raffaella Giavazzi, Benoı̂t Chabot, S J Lu, Sheldon Rowan, Angela Garofalo, Robert S. Kerbel, Carmen Ghilardi, Sophie Dupuis and Raymund J. Wellinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Blood.

In The Last Decade

Maria Rosa Bani

62 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Rosa Bani Italy	28	1.6k	789	509	384	304	62	2.4k
Johan Dixelius Sweden	16	1.5k 1.0×	458 0.6×	562 1.1×	196 0.5×	315 1.0×	18	2.1k
Corinne Wendling France	25	1.7k 1.1×	536 0.7×	718 1.4×	526 1.4×	164 0.5×	33	2.9k
Umut Şahin France	14	1.2k 0.8×	622 0.8×	254 0.5×	280 0.7×	286 0.9×	20	1.9k
Roger A. Moorehead Canada	27	1.8k 1.1×	1.1k 1.4×	1.0k 2.0×	286 0.7×	116 0.4×	69	2.8k
Michael P. Sanderson Germany	17	1.5k 1.0×	806 1.0×	569 1.1×	287 0.7×	217 0.7×	42	2.4k
Jun Chung United States	24	1.6k 1.0×	515 0.7×	546 1.1×	405 1.1×	618 2.0×	39	2.3k
E. Tischer United States	7	1.8k 1.1×	441 0.6×	554 1.1×	212 0.6×	120 0.4×	8	2.3k
Rosemary A. Walker United Kingdom	31	1.5k 1.0×	1.0k 1.3×	720 1.4×	293 0.8×	340 1.1×	72	2.8k
Brigitte Mack Germany	29	1.5k 1.0×	1.4k 1.7×	656 1.3×	772 2.0×	166 0.5×	70	3.2k

Countries citing papers authored by Maria Rosa Bani

Since Specialization

Citations

This map shows the geographic impact of Maria Rosa Bani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Rosa Bani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Rosa Bani more than expected).

Fields of papers citing papers by Maria Rosa Bani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Rosa Bani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Rosa Bani. The network helps show where Maria Rosa Bani may publish in the future.

Co-authorship network of co-authors of Maria Rosa Bani

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Rosa Bani. A scholar is included among the top collaborators of Maria Rosa Bani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Rosa Bani. Maria Rosa Bani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Decio, Alessandra, Mark R. Albertella, Joanne Wilson, et al.. (2023). The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. Cancer Research Communications. 3(3). 489–500. 9 indexed citations

Panini, Nicolò, Paola Fabbrizio, Cristina Matteo, et al.. (2023). Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells. OncoImmunology. 12(1). 2239035–2239035. 5 indexed citations

Anastasia, Alessia, Antonio Ramos‐Montoya, Giovanna Chiorino, et al.. (2022). The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases. Molecular Cancer Therapeutics. 21(4). 555–567. 25 indexed citations

Guffanti, Federica, M.F. Alvisi, Alessia Anastasia, et al.. (2021). Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts. British Journal of Cancer. 126(1). 120–128. 25 indexed citations

Decio, Alessandra, et al.. (2021). Abstract P217: The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer. Molecular Cancer Therapeutics. 20(12_Supplement). P217–P217. 1 indexed citations

Ricci, Francesca, Federica Guffanti, Roberta Affatato, et al.. (2020). Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer.. PubMed. 10(2). 572–580. 11 indexed citations

Falcetta, Francesca, et al.. (2017). Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer. Cancer Research. 77(23). 6759–6769. 6 indexed citations

Bani, Maria Rosa, Alessandra Decio, Raffaella Giavazzi, & Carmen Ghilardi. (2017). Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists. Angiogenesis. 20(2). 233–241. 23 indexed citations

Ricci, Francesca, Francesca Bizzaro, Marta Cesca, et al.. (2014). Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations. Cancer Research. 74(23). 6980–6990. 104 indexed citations

10.

Moschetta, Michele, Francesca Pretto, Alexander Berndt, et al.. (2012). Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts. Cancer Research. 72(7). 1814–1824. 78 indexed citations

11.

Moretti, Roberta M., Stefania Mai, Marina Montagnani Marelli, et al.. (2010). Dual Targeting of Tumor and Endothelial Cells by Gonadotropin-Releasing Hormone Agonists to Reduce Melanoma Angiogenesis. Endocrinology. 151(10). 4643–4653. 13 indexed citations

12.

Silini, Antonietta Rosa, Carmen Ghilardi, Sergio Bernasconi, et al.. (2009). Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype. Clinical & Experimental Metastasis. 27(1). 43–53. 15 indexed citations

13.

Ubezio, Paolo, Angela Garofalo, Patrizia Borsotti, et al.. (2006). The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis. Clinical Cancer Research. 12(6). 1839–1849. 51 indexed citations

14.

Pak, Brian J., Maria Rosa Bani, Shi‐Jiang Lu, et al.. (2000). Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications. Oncogene. 19(3). 395–402. 47 indexed citations

15.

Taraboletti, Giulia, Veronica Vergani, Roberta Ceruti, et al.. (2000). Posttranscriptional Stimulation of Endothelial Cell Matrix Metalloproteinases 2 and 1 by Endothelioma Cells. Experimental Cell Research. 258(2). 384–394. 39 indexed citations

16.

Chirivi, Renato G.S., Giulia Taraboletti, Maria Rosa Bani, et al.. (1999). Human Immunodeficiency Virus-1 (HIV-1)-Tat Protein Promotes Migration of Acquired Immunodeficiency Syndrome–Related Lymphoma Cells and Enhances Their Adhesion to Endothelial Cells. Blood. 94(5). 1747–1754. 25 indexed citations

17.

Dupuis, Sophie, et al.. (1998). Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nature Genetics. 19(2). 199–202. 241 indexed citations

18.

Huang, Xiao, Maria Rosa Bani, S J Lu, et al.. (1994). The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo.. Proceedings of the National Academy of Sciences. 91(15). 6924–6928. 182 indexed citations

19.

Ben‐David, Yaacov, et al.. (1992). Retroviral Insertions Downstream of the Heterogeneous Nuclear Ribonucleoprotein Al Gene in Erythroleukemia Cells: Evidence that Al Is Not Essential for Cell Growth. Molecular and Cellular Biology. 12(10). 4449–4455. 72 indexed citations

20.

Corallini, Alfredo, Maurizio Gianni’, Cristina Mantovani, et al.. (1991). Transformation of human cells by recombinant DNA molecules containing BK virus early region and the human activated c-H-ras or c-myc oncogenes. Institutional Research Information System University of Ferrara (University of Ferrara). 4(1). 24–34. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact